| Mr Erik Garcia, FNP | |
|
7812 Gateway Blvd E Ste 230, El Paso, TX 79915-1837 | |
| (915) 219-4300 | |
| Not Available |
| Full Name | Mr Erik Garcia |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Family |
| Location | 7812 Gateway Blvd E Ste 230, El Paso, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881150506 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | AP140672 (Texas) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | AP140672 (Texas) | Primary |
| Entity Name | Erik Garcia Fnp C Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285353045 PECOS PAC ID: 2668830431 Enrollment ID: O20230627000752 |
News Archive
New research from QUT shows preventable hospitalisation from diabetic foot disease is costing Australia hundreds of millions of dollars each year.
Indiana officials contend the state's Planned Parenthood chapter could end a fierce legal dispute over abortion funding by simply separating its abortion business from other services. But advocates for the organization view the idea as a red herring pushed by critics seeking to entirely defund the country's largest abortion provider. Their skepticism is fueled by experiences from Planned Parenthood chapters in two other states where non-abortion services were targeted even after such a split.
Seth Bordenstein, associate professor of biological sciences and pathology, microbiology and immunology, has been awarded a $950,000 grant from the National Science Foundation for research into the regulation of bacterial infections that are passed from mother to offspring.
New research from the University of California, San Diego Department of Medicine, Division of Nephrology, shows that the anti-rejection drug sirolimus (brand name Rapamune) may help prolong the clinical benefit of transplanted kidneys and delay rejection, especially in patients who do not regularly take their prescribed medications (are "non-compliant"). While the transplant field has been highly successful at reducing rejection and graft loss in the first year, post-transplant, reducing risk for graft rejection in the long-term has proved more difficult.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Erik Garcia, FNP 5746 Trowbridge Dr, El Paso, TX 79925-3341 Ph: (915) 219-4300 | Mr Erik Garcia, FNP 7812 Gateway Blvd E Ste 230, El Paso, TX 79915-1837 Ph: (915) 219-4300 |
News Archive
New research from QUT shows preventable hospitalisation from diabetic foot disease is costing Australia hundreds of millions of dollars each year.
Indiana officials contend the state's Planned Parenthood chapter could end a fierce legal dispute over abortion funding by simply separating its abortion business from other services. But advocates for the organization view the idea as a red herring pushed by critics seeking to entirely defund the country's largest abortion provider. Their skepticism is fueled by experiences from Planned Parenthood chapters in two other states where non-abortion services were targeted even after such a split.
Seth Bordenstein, associate professor of biological sciences and pathology, microbiology and immunology, has been awarded a $950,000 grant from the National Science Foundation for research into the regulation of bacterial infections that are passed from mother to offspring.
New research from the University of California, San Diego Department of Medicine, Division of Nephrology, shows that the anti-rejection drug sirolimus (brand name Rapamune) may help prolong the clinical benefit of transplanted kidneys and delay rejection, especially in patients who do not regularly take their prescribed medications (are "non-compliant"). While the transplant field has been highly successful at reducing rejection and graft loss in the first year, post-transplant, reducing risk for graft rejection in the long-term has proved more difficult.
› Verified 7 days ago